Posted on March 5th, 2014
Daniel O’Connor has fifteen years of executive, legal, and regulatory experience in the biopharmaceutical industry. As a former Captain in the U.S. Marines, criminal prosecutor in New Jersey, and executive of several pharmaceutical companies, Dan is uniquely qualified to be the leader of Advaxis, Inc.
Company OverviewAdvaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in Phase 1 and Phase 2 clinical trials for HPV-associated diseases including invasive cervical cancer, HPV-associated head and neck cancer, and anal cancer. Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence. ... Learn More »
By now you’ve heard me and several of our guest bloggers mention how hot the cancer immunotherapy space is and you mus...Read More »
Posted on February 28th, 2014
“Every man gotta right to decide his own destiny” -Bob Marley The “Right to Try” bill is making its way t...Read More »
Posted on February 27th, 2014
The CodeSmart™ Group was proud to announce this week the launch of our new clinical documentation software and referen...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
We are an exclusive, online media publication where public and privatively held firms alike share insights about their companies and industries...Learn More »